"Iron sharpens iron, so one man sharpens another." Proverbs 27:17
Patient-Specific Cancer Testing
CorrectChemo® is a clinical pathology lab that offers patient-specific chemotherapy testing to help oncologists determine the best cancer treatment plans for their patients. CorrectChemo® uses a patented technology called the Microculture Kinetic (MiCK) assay®, which measures apoptosis (cell death) induced in a specific patient’s cancer cells by chemotherapy.
CorrectChemo's® assay is the ONLY test on the market that evaluates the chemotherapeutic drug effect for a specific patient and can tell which chemotherapy drugs are most effective. The assay has been used successfully in more than 50 different tumor types
Learn about the benefits of CorrectChemo's® MiCK assay® from CorrectChemo's® Chief Medical Officer, Dr. Cary Presant.